2 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Nov 01, 2024
3 FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit! Oct 31, 2024
4 New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Oct 30, 2024
6 New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity Oct 27, 2024
Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Nov 02, 2024
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Nov 21, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
Read More Medical New Developments In Gastric Cancer Research: Keytruda In Combination With Chemotherapy Significantly Improves Survival In Patients With Advanced Disease! Nov 09, 2024
